Found 5 matching trials
FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy PHASE1 The purpose of this study is to test a new way of treating the most common ...
Show More Location
Albert Einstein College of Medicine
Learn More & Join Trial
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors PHASE1 This phase I trial evaluates the safety and effectiveness of in situ immuno...
Show More Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Learn More & Join Trial
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer PHASE2 This phase II trial compares the effectiveness of cemiplimab with CDX-1140 ...
Show More Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Learn More & Join Trial
A Maintenance Therapy Study of Odetiglucan With CDX-1140 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma PHASE1 The primary objective of this maintenance therapy study is to identify the ...
Show More Location
HonorHealth Research Institute
Learn More & Join Trial
Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer PHASE2 This phase II trial tests whether pembrolizumab combined with bevacizumab w...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial